Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor-Unfractionated Heparin Complex Inhibits Early Graft Thrombosis

BACKGROUND: Bypass graft surgery remains to be an important treatment option for left main and multivessel coronary artery disease. Approximately 2% of saphenous vein grafts are lost immediately after the coronary artery bypass graft operations and 12% in the first month due to thrombosis. AIMS: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Akşit, Ercan, Kurt, Tolga, Büyük, Başak, Çokkalender, Ömer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424184/
https://www.ncbi.nlm.nih.gov/pubmed/32353222
http://dx.doi.org/10.4274/balkanmedj.galenos.2020.2020.1.128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424184/
https://www.ncbi.nlm.nih.gov/pubmed/32353222
http://dx.doi.org/10.4274/balkanmedj.galenos.2020.2020.1.128

Ejemplares similares